从人权保障视角看我国《疫苗管理法》的制度设计

2019年12月1日,由第十三届全国人大常委会第十一次会议表决通过的《中华人民共和国疫苗管理法》正式实施。该法是基于近些年来发生的多起假劣疫苗事件为社会背景,回应社会关切而制定的旨在加强疫苗监管,保证疫苗质量,保护接种对象特别是婴幼儿的生命健康,维护社会公共卫生安全的一部专门性法律。该法设计了严密的制度体系,设置了一系列的制度规则,体现了"四个最严",是我国药品领域最严的管理法。从人权角度看,它不仅是一部《疫苗管理法》,更是一部人权保障法。     

Protect Our Children: Vaccination Exemptions Can Establish Child Abuse and Neglect

The need to protect public health has increased as the anti‐vaccine movement is on the rise. Exemptions to vaccination requirements have become more lax, and parents find ways to avoid vaccinating their children, thereby exposing not only their children to the dangers of serious diseases, but other children as well. This Note proposes a federal statute mandating that parents subject their children between the ages of infancy and 6 to acquire vaccinations for all diseases recommended by the Centers for Disease Control and Prevention unless a licensed physician recommends otherwise.     

禽流感二价抗原油乳剂灭活疫苗的研制

以禽流感病毒(AIV)H5N4株、H7N3株为抗原研制了H5N4-H7N3二价油乳剂灭活疫苗,并对其物理性状、安全性、免疫效力、保存期及抗体消长规律进行了检测.结果表明,试验鸡疫苗在免疫后3周到9个月内对AIV-H5N4的攻击均获全部保护.疫苗4℃保存15个月,其免疫效力没有下降.